05 September 1994 00:00 [Source: ICB]
Microbix Biosystems of Toronto is 'clearing the final hurdles' to market a new, genetically-engineered rabies vaccine, licensed from McMaster University in Hamilton, Ontario. Testing will now take place at the Animal Disease Institute in Ottawa. The vaccine is intended for animals such as foxes, skunks and racoons as well as humans.
For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.
Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.
Sample issue >>
My Account/Renew >>
Register for online access >>
|ICIS Top 100 Chemical Companies|
|Download the listing here >>|